Novozymes secures loan from NIB

The enzyme maker has received a loan of EUR 100m to fund research and development.
Photo: Novozymes/PR
Photo: Novozymes/PR
BY MARKETWIRE, TRANSLATED BY CHRISTOFFER ØSTERGAARD

The Nordic Investment Bank and Danish biotech company Novozymes have signed an agreement for a loan of EUR 100m, which will be used to cover expenses tied to research and development.

The loan comes with a maturity of ten years and will support the company's R&D activities in biosolutions for consumers as well as biosolutions for agriculture and industry.

This marks NIB's sixth loan agreement with Novozymes.

Novozymes waves bye to corona still looming in rear-view mirror

Bioenergy division blasts ahead at Novozymes 

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Further reading